Cargando…
The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas
SIMPLE SUMMARY: The recommended management of marginally resectable or unresectable soft tissue sarcomas is an attempt of neoadjuvant therapy. The use of neoadjuvant chemotherapy is limited in low-grade tumors, sarcomas with chemoresistant pathology or in unfit patients. There is a growing evidence...
Autores principales: | Spałek, Mateusz Jacek, Borkowska, Aneta Maria, Telejko, Maria, Wągrodzki, Michał, Niebyłowska, Daria, Uzar, Aldona, Białobrzeska, Magdalena, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000962/ https://www.ncbi.nlm.nih.gov/pubmed/33809547 http://dx.doi.org/10.3390/cancers13061332 |
Ejemplares similares
-
Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022) -
Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021) -
Coronavirus Disease (COVID-19) Outbreak: Hypofractionated Radiotherapy in Soft Tissue Sarcomas as a Valuable Option in the Environment of Limited Medical Resources and Demands for Increased Protection of Patients
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020) -
Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020) -
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)